- Key facts & figures
- Sanofi share
- Analysts / Vara Consensus
- Reports & publications
- Results & presentations
- Corporate governance
Annual General Meetings
- Our publications
- Being a shareholder
- Becoming a shareholder
- Shareholders committee
- US investors
- Regulated information in France
Investor Relations Awards
- Get to know Sanofi
- Working at Sanofi
- Our Expertise, your future
- Join Sanofi
- Being our partner
- Understanding science discovering
- Developing and marketing innovative solutions
- Manufacturing and supply
- Healthcare Solutions
- Our approach
- Improving access to healthcare
- Working together
- Acting ethically
- Preserving the environment
- ‘LE HUB’ eMAG
You are here:
Relations with healthcare professionals
We are committed to respecting high standards of ethical conduct in our dealings with healthcare professionals in the interest of patients.
We engage healthcare professionals for their expertise in many areas – from asking them to lead training programs to soliciting their feedback and insights about our products. We interact with physicians to provide information about our products as well as scientific, medical and educational information.
Transparency in our interactions
Why is transparency important?
Collaboration between industry, healthcare professionals and healthcare organizations is a vital need in enabling the development and effective use of new medicines and shaping the future of research. Bringing greater transparency to these, already well-regulated and legitimate relationships aim to build greater understanding of industry, healthcare professionals and healthcare organizations collaboration.
What is Sanofi’s commitment in regards to transparency?
We believe that transparency reflects on credibility and engenders confidence in our company, and we are committed to complying with all applicable rules and regulations governing transparency. Each year we publicly disclose the transfers of value made to healthcare professionals in the US and Europe, either on an individual or an aggregate basis.
Across Europe and by end of June 2016, Sanofi as a member company of EFPIA (The European Federation of Pharmaceutical Industries And Associations) is disclosing details of its collaborations with healthcare professionals (HCPs) and healthcare organizations (HCOs). The disclosures include transfers of value made for activities such as research and educational grants to healthcare organizations as well as transfers of value to individual HCPs such as sponsorship to attend educational meetings, speaker fees, fees for consultancy activities and fees for advisory boards.
Why are we working with healthcare professionals and healthcare organisations?
Healthcare professionals and organisations with whom we work provide us with valuable, independent and expert knowledge derived from their clinical and disease management experience. This expertise contributes significantly to our efforts to improve the quality of patient care, with benefits for individuals and society at large.
Access to the full list of data publication sites:
Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to Healthcare Professionals and Organisations our company is collaborating / has relationships with, following the objectives and provisions included in the applicable Codes.
Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable Codes that our company signed off to.
These publications do not grant a general permission for those accessing our websites or the national platforms to undertake additional processing of the Recipient’s data.
For a good understanding of the reporting included in our disclosures as published on these websites, we refer to the Methodological Notes that clarify the meaning and content of the transfers of value reported.
March 24, 2017
March 13, 2017
- Company sites
- Legal Notice
- Cookies policy
- Cookies settings
- Corporate Code of Ethics